As part of the plan, Amazon has agreed to purchase 100,000 electric delivery vans from vehicle manufacturer Rivian.Technologyread more
Vice President Pence's sit-down with CNBC's Joe Kernen comes as President Donald Trump's White House navigates a forest of thorny political issues.Delivering Alpharead more
The plan will allow Medicare to negotiate lower prices on as many as 250 drugs and apply those discounts to private health plans.Health and Scienceread more
President Donald Trump on Thursday filed a lawsuit against Manhattan District Attorney Cyrus Vance Jr. and his longtime accounting firm Mazars.Politicsread more
Hedge fund titan Leon Cooperman said he's concerned about a shift to the left in the political landscape, which could harm the economy and the stock market.Delivering Alpharead more
Trian Partners co-founder and CEO Nelson Peltz explained to CNBC on Thursday the backstory to his firm's position in struggling General Electric.Delivering Alpharead more
More than half of the patients have been younger than 25 and 16% are younger than 18, CDC principal deputy director Anne Schuchat said.Health and Scienceread more
The Democratic-held House plans to move forward with a bill to fund the government through Nov. 21 and avoid another government shutdown.Politicsread more
Jim Chanos, founder of Kynikos Associates, revealed Thursday a stock he has been shorting for years: kidney dialysis company DaVita.Delivering Alpharead more
GM's usage of temporary workers, potential closure of plants and health care contributions remain major sticking points, according to people familiar with the talks.Autosread more
As investors try to get a hold of the ever-changing market landscape, CNBC's Jim Cramer said Friday they should keep an eye on Ulta Salon Cosmetics' stock amid the beauty retailer's latest earnings beat.
"This was an ideal stock that was up 8 points after it reported last night and now it's barely up 1 percent. This is your stock to watch, because this was magnificent," Cramer said on "Squawk on the Street," referring to the earnings report and CEO Mary Dillon's conference call.
"If it can't close up, we really are in a little more of a sick market than we thought. This was textbook," Cramer added.
The company reported fiscal second-quarter earnings per share and revenue after the bell Thursday that were above Wall Street expectations. Its stock was higher midmorning Friday.
Disclosure: Cramer's trust did not own Ulta stock when this article was published.